AI-designed drug for inflammatory bowel disease enters human clinical trials: 'A significant need'

Inflammatory bowel disease (IBD) impacts 1.6 million people in the U.S. — and a new artificial intelligence drug from Insilico Medicine could help alleviate symptoms. The company's CEO shares details.


http://dlvr.it/T1zb6Q